lenzilumab
Showing 1 - 5 of 5
Relapsed/Refractory Large B-cell Lymphoma Trial in United States (Cyclophosphamide, Fludarabine, Lenzilumab)
Terminated
- Relapsed/Refractory Large B-cell Lymphoma
- Cyclophosphamide
- +3 more
-
Palo Alto, California
- +9 more
Aug 26, 2022
Cancer, Covid19, Respiratory Viral Infection Trial in Melbourne (Interferon alfa, Selinexor, Lenzilumab)
Recruiting
- Cancer
- +2 more
- Interferon alfa
- +2 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Aug 11, 2021
Coronavirus Disease 2019 (COVID-19) Pneumonia Trial in Brazil, United States (Lenzilumab, Standard of Care)
Active, not recruiting
- Coronavirus Disease 2019 (COVID-19) Pneumonia
- Lenzilumab
- Standard of Care
-
Phoenix, Arizona
- +28 more
Mar 1, 2021
Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa, Rochester (lenzilumab)
Completed
- Chronic Myelomonocytic Leukemia (CMML)
- lenzilumab
-
Tampa, Florida
- +1 more
Feb 26, 2020
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022